COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD
HC Q study #128
Source   PDF   Share   Tweet
See all 143 studies
9/22
Positive
Late treatment study
Serrano et al., Ann. Oncol., 2020, Sep, 31, S1026, doi:10.1016/j.annonc.2020.08.1830 (Peer Reviewed)
COVID-19 and lung cancer: What do we know?
Small retrospective study of 22 lung cancer patients, 14 treated with HC Q+AZ, showing HC Q+AZ mortality relative risk RR 0.57, p = 0.145.
death, ↓43.0%, p=0.14
Source   PDF   Share   Tweet
See all 143 studies
Please send us corrections, updates, or comments.
Submit